Osteonecrosis of the Jaw in a Patient on Denosumab
Top Cited Papers
- 31 May 2010
- journal article
- case report
- Published by Elsevier BV in Journal of Oral and Maxillofacial Surgery
- Vol. 68 (5), 959-963
- https://doi.org/10.1016/j.joms.2009.10.010
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous BisphosphonatesJournal of Clinical Oncology, 2009
- Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?Bone, 2007
- Osteoclasts: What Do They Do and How Do They Do It?The American Journal of Pathology, 2007
- OPG/membranous–RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradationBone, 2006
- Novel Approaches in the Management of Myeloma-Related Skeletal ComplicationsSupportive Cancer Therapy, 2006
- Bisphosphonate Complications Including Osteonecrosis of the JawHematology, 2006
- Osteonecrosis of the Jaw and BisphosphonatesThe New England Journal of Medicine, 2005
- Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal WomenThe New England Journal of Medicine, 2004
- Bisphosphanates and Oral Cavity Avascular Bone NecrosisJournal of Clinical Oncology, 2003
- Osteoclast differentiation and activationNature, 2003